EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1

Exhibit 99.1

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million
Represents 3% Year-Over-Year Decrease

In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares

YOKNEAM, Israel, April 28, 2025 - InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2025.
 
First Quarter 2025 Highlights:

 
Quarterly GAAP revenues of $77.9 million, compared to $80.3 million in the first quarter of 2024.
 
Quarterly revenues from consumables and service of $20.2 million, a decrease of 10% compared to the first quarter of 2024.
 
GAAP operating income of $15.6 million, *non-GAAP operating income of $18.1 million.
 
Total cash position of $512.9 million as of March 31, 2025, including cash and cash equivalents, marketable securities and short-term bank deposits.
 
In April 2025, completed the repurchase of 6.95 million ordinary shares, returning $127 million of capital to shareholders year-to-date through a share repurchase program.

U.S. GAAP Results
(U.S. dollars in thousands, except for per share data)
 
         Q1 2025
  Q1 2024
Revenues
           $77,874
$80,284
Gross Margins
              78%
80%
Net Income
$18,201
$23,696
Earnings per Diluted Share
$0.26
$0.28
*Non-GAAP Results
(U.S. dollars in thousands, except for per share data)
 
         Q1 2025
    Q1 2024
Gross Margins
79%
80%
Net Income
$21,395
$27,679
Earnings per Diluted Share
$0.31
$0.32

*Please refer to “Use of Non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and related tax adjustments.
 

Management Comments
 
“In Q1 2025, our performance reflected continued pressure from a challenging macroeconomic environment and weakened consumer demand,” said Moshe Mizrahy, Chief Executive Officer of InMode. “While these external factors impacted results, we remain focused on executing our strategy. This includes driving operational excellence, investing in innovation, and pursuing disciplined capital allocation.”

“We are pleased with our international performance in Q1, particularly in Europe, where we achieved record revenue despite ongoing market headwinds. Looking forward, we believe the recent launch of our OptimasMAX, and Ignite platforms reinforces our commitment to innovation while offering the gold standard technology in aesthetics,” Mizrahy concluded.

Yair Malca, Chief Financial Officer of InMode, added, “Our strong balance sheet provides the stability and flexibility to navigate near-term challenges while continuing to invest in our long-term growth and recruit the best talent in the industry. We’re pleased to report that, earlier this month, we completed our fifth share repurchase program of 6.95 million shares approved by our board of directors in February 2025, for a total of $127 million, underscoring our commitment to disciplined capital allocation and returning value to shareholders. In fact, our total capital return to shareholders in the past 12 months was more than $412 million, executed via share repurchases representing approximately 27% of our share capital.

“As always, we continue to explore all avenues for disciplined capital allocation, including additional share repurchases, potential dividends, and strategic M&A opportunities. Our approach remains focused on maximizing long-term shareholder value while maintaining a strong and flexible balance sheet. In addition, international markets accounted for a larger share of total revenue while the U.S. continued to experience challenging headwinds, resulting in a 4%–5% decline in operating margins. We anticipate this trend will persist through the end of the year. Lastly, with U.S. tariffs at their current levels at 10%, we expect an impact of approximately 2%–3% on gross margins,” Malca concluded.

First Quarter 2025 Financial Results
 
Total GAAP revenues for the first quarter of 2025 were $77.9 million, a decrease of 3% compared to $80.3 million in first quarter of 2024.

GAAP gross margin for the first quarter of 2025 was 78%, compared to a gross margin of 80% for the first quarter of 2024. *Non-GAAP gross margin for the first quarter of 2025 was 79%, compared to a gross margin of 80% for the first quarter of 2024.

GAAP operating margin for the first quarter of 2025 was 20%, compared to 23% in the first quarter of 2024. *Non-GAAP operating margin for the first quarter of 2025 was 23% compared to 27% for the first quarter of 2024. This decrease was primarily attributable to the increase in cost of goods and marketing activity due to launch of new products.
 
InMode reported GAAP net income of $18.2 million, or $0.26 per diluted share, in the first quarter of 2025, compared to $23.7 million, or $0.28 per diluted share, in the first quarter of 2024. On a *non-GAAP basis, InMode reported net income of $21.4 million, or $0.31 per diluted share, in the first quarter of 2025, compared to $27.7 million, or $0.32 per diluted share, in the first quarter of 2024.
 
As of March 31, 2025, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $512.9 million.
 

2025 Financial Outlook
 
Management provided an outlook for the full year of 2025 ending December 31, 2025. Based on our current estimates, management expects:

Revenues between $395 to $405 million
 
*Non-GAAP gross margin between 78% and 80%, compared to previous guidance of 80% to 82%
 
*Non-GAAP income from operations to be between $101 million and $106 million, compared to previous guidance of $130 million to $135 million
 
*Non-GAAP earnings per diluted share between $1.64 to $1.68, compared to previous guidance of $1.95 to $1.99
 
This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See “Forward-Looking Statements” for additional information.
 
*Please refer to “Use of Non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and related tax adjustments.
 
The Current Situation in Israel
 
Regarding the current situation in Israel, Israel and Hamas agreed to a ceasefire agreement; the first phase of such ceasefire began in January 2025. During March 2025, the ceasefire collapsed. Since its collapse, fighting has been carried out at low intensity, amid international attempts to end the war. We remain confident in our ability to continue our R&D and manufacturing activities while maintaining the safety and well-being of our employees.

Use of Non-GAAP Financial Measures
 
In addition to InMode’s operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin. Because these measures are used in InMode’s internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode’s economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode’s GAAP operating results, allows investors to more effectively evaluate and compare InMode’s performance to that of its peers, although InMode’s presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.
 
Conference Call Information

Mr. Moshe Mizrahy, Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer will host a conference call today, April 28, 2025, at 8:30 a.m. Eastern Time to discuss the first quarter 2025 financial results.
 
The Company encourages participants to pre-register for the conference call using the following link:  
https://dpregister.com/sreg/10198516/fede138cb8.

Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.


U.S. Toll-Free Dial-in Number: 1-833-316-0562
Israel Toll- Free Dial-in Number: 1-80-921-2373
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=jNwaTGkH
At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time

The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from April 28, 2025, at 12 p.m. Eastern Time to May 12, 2025, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

Replay Dial-in U.S TOLL-FREE: 1-877-344-7529
Replay Dial-in Canada TOLL-FREE: 1-855-669-9658
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 3039661

To access the replay using an international dial-in number, please select the link below:
https://services.choruscall.com/ccforms/replay.html

A replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.

About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 4, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
 
Company Contact:
Yair Malca
Chief Financial Officer
Phone: (949) 305-0108
Email: Yair.Malca@inmodemd.com
Investor Relations Contact:
Miri Segal
MS-IR LLC
Email: ir@inmodemd.com


INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended
March 31,
 
   
2025
   
2024
 
REVENUES
   
77,874
     
80,284
 
COST OF REVENUES
   
16,963
     
16,365
 
GROSS PROFIT
   
60,911
     
63,919
 
OPERATING EXPENSES:
               
Research and development
   
2,895
     
3,518
 
Sales and marketing
   
39,727
     
39,795
 
General and administrative
   
2,671
     
2,514
 
TOTAL OPERATING EXPENSES
   
45,293
     
45,827
 
OPERATIONS INCOME
   
15,618
     
18,092
 
Finance income, net
   
6,859
     
7,984
 
INCOME BEFORE INCOME TAXES
   
22,477
     
26,076
 
INCOME TAXES
   
4,276
     
2,380
 
NET INCOME
   
18,201
     
23,696
 
                 
 EARNINGS PER SHARE:
               
Basic
   
0.26
     
0.28
 
Diluted
   
0.26
     
0.28
 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands)
               
Basic
   
68,760
     
84,523
 
Diluted
   
69,435
     
85,965
 


INMODE LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
March 31,
2025
   
December 31,
2024
 
Assets
           
CURRENT ASSETS:
           
Cash and cash equivalents
   
145,948
     
155,329
 
Marketable securities
   
224,457
     
267,688
 
Short-term bank deposits
   
142,520
     
173,455
 
Accounts receivable, net of allowance for credit losses
   
32,367
     
36,335
 
Prepaid expense and other receivables
   
25,564
     
22,097
 
Inventories
   
63,781
     
59,548
 
TOTAL CURRENT ASSETS
   
634,637
     
714,452
 
    NON-CURRENT ASSETS:
               
Accounts receivable, net of allowance for credit losses
   
2,694
     
3,176
 
Deferred income tax asset
   
55,338
     
56,285
 
Operating lease right-of-use assets
   
9,133
     
8,732
 
Property and equipment, net
   
2,233
     
2,322
 
Other investments
   
700
     
700
 
TOTAL NON-CURRENT ASSETS
   
70,098
     
71,215
 
TOTAL ASSETS
   
704,735
     
785,667
 
Liabilities and shareholders’ equity
               
CURRENT LIABILITIES:
               
Accounts payable
   
15,052
     
13,782
 
Contract liabilities
   
15,861
     
16,755
 
Other liabilities
   
41,745
     
39,314
 
TOTAL CURRENT LIABILITIES
   
72,658
     
69,851
 
    NON-CURRENT LIABILITIES:
               
Contract liabilities
   
3,393
     
3,336
 
Other liabilities
   
3,668
     
3,356
 
Operating lease liabilities
   
5,588
     
5,311
 
TOTAL NON-CURRENT LIABILITIES
   
12,649
     
12,003
 
TOTAL LIABILITIES
   
85,307
     
81,854
 
                 
TOTAL SHAREHOLDERS’ EQUITY
   
619,428
     
703,813
 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
   
704,735
     
785,667
 


INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended
March 31,
 
   
2025
   
2024
 
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net income
   
18,201
     
23,696
 
Adjustments required to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
   
174
     
165
 
Share-based compensation expenses
   
2,518
     
3,983
 
Change in allowance for credit losses of trade receivable
   
(94
)
   
187
 
Loss (gains) on marketable securities, net
   
(2
)
   
29
 
Finance income, net
   
(1,574
)
   
(4,757
)
Deferred income taxes, net
   
896
     
(37
)
Changes in operating assets and liabilities:
               
Decrease in accounts receivable
   
4,544
     
9,308
 
Increase in other receivables
   
(3,532
)
   
(2,669
)
Increase in inventories
   
(4,233
)
   
(6,507
)
Increase (decrease) in accounts payable
   
1,270
     
(743
)
Decrease in other liabilities
   
(3,287
)
   
(7,803
)
Increase (decrease) in contract liabilities (current and non-current)
   
(837
)
   
9,262
 
Net cash provided by operating activities
   
14,044
     
24,114
 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Investment in short-term deposits
   
-
     
(31,297
)
Proceeds from short-term deposits
   
31,297
     
-
 
Purchase of fixed assets
   
(85
)
   
(112
)
Purchase of marketable securities
   
(20,877
)
   
(121,564
)
Proceeds from sale of marketable securities
   
3,003
     
13,465
 
Proceeds from maturity of marketable securities
   
62,147
     
92,118
 
Net cash provided by (used in) investing activities
   
75,485
     
(47,390
)
CASH FLOWS FROM FINANCING ACTIVITIES:
               
  Repurchase of ordinary shares
   
(99,960
)
   
-
 
  Exercise of options
   
494
     
234
 
Net cash provided by (used in) financing activities
   
(99,466
)
   
234
 
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
   
556
     
(439
)
NET DECREASE IN CASH AND CASH EQUIVALENTS
   
(9,381
)
   
(23,481
)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
   
155,329
     
144,411
 
CASH AND CASH EQUIVALENTS AT END OF PERIOD
   
145,948
     
120,930
 


INMODE LTD.
CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

 
Three months ended
March 31,
 

 
2025
   
2024
 
Revenues by Category:
                       
                         
Capital Equipment revenues - United States
   
29,542
     
38
%
   
30,859
     
38
%
Capital Equipment revenues - International
   
28,133
     
36
%
   
26,923
     
34
%
Total Capital Equipment revenues
   
57,675
     
74
%
   
57,782
     
72
%
Consumables and service revenues
   
20,199
     
26
%
   
22,502
     
28
%
Total Revenue
   
77,874
     
100
%
   
80,284
     
100
%

 
Three months ended
March 31,
 
   
2025
   
2024
 
   
%
   
%
 
   
United States
   
International
   
Total
   
United States
   
International
   
Total
 
Revenues by Technology:
                                   
Minimally Invasive
   
93
     
79
     
87
     
87
     
80
     
84
 
Hands-Free
   
3
     
2
     
3
     
8
     
3
     
5
 
Non-Invasive
   
4
     
19
     
10
     
5
     
17
     
11
 
     
100
     
100
     
100
     
100
     
100
     
100
 


INMODE LTD.
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
 INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)

 
Three months ended March 31, 2025
   
Three months ended March 31, 2024
 
   
GAAP
   
Share Based
Compensation
   
Non-GAAP
   
GAAP
   
Share Based
Compensation
   
Non-GAAP
 
REVENUES
   
77,874
     
-
     
77,874
     
80,284
     
-
     
80,284
 
COST OF REVENUES
   
16,963
     
(310
)
   
16,653
     
16,365
     
(409
)
   
15,956
 
GROSS PROFIT
   
60,911
     
310
     
61,221
     
63,919
     
409
     
64,328
 
OPERATING EXPENSES:
                                               
Research and development
   
2,895
     
(222
)
   
2,673
     
3,518
     
(428
)
   
3,090
 
Sales and marketing
   
39,727
     
(1,763
)
   
37,964
     
39,795
     
(2,883
)
   
36,912
 
General and administrative
   
2,671
     
(223
)
   
2,448
     
2,514
     
(263
)
   
2,251
 
TOTAL OPERATING EXPENSES
   
45,293
     
(2,208
)
   
43,085
     
45,827
     
(3,574
)
   
42,253
 
OPERATIONS INCOME
   
15,618
     
2,518
     
18,136
     
18,092
     
3,983
     
22,075
 
Finance income, net
   
6,859
     
-
     
6,859
     
7,984
     
-
     
7,984
 
INCOME BEFORE INCOME TAXES
   
22,477
     
2,518
     
24,995
     
26,076
     
3,983
     
30,059
 
INCOME TAXES
   
4,276
     
(676
)
   
3,600
     
2,380
     
-
     
2,380
 
NET INCOME
   
18,201
     
3,194
     
21,395
     
23,696
     
3,983
     
27,679
 
                                                 
EARNINGS PER SHARE:
                                               
Basic
   
0.26
             
0.31
     
0.28
             
0.33
 
Diluted
   
0.26
             
0.31
     
0.28
             
0.32
 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands)
                                               
Basic
   
68,760
             
68,760
     
84,523
             
84,523
 
Diluted
   
69,435
             
69,611
     
85,965
             
86,563